Neurocrine gives up on Parkinsons drug Ongentys - FiercePharma
| TH Stock | CAD 1.68 0.06 3.45% |
About 61% of Theratechnologies' investor base is looking to short. The analysis of the overall investor sentiment regarding Theratechnologies suggests that many traders are alarmed. Theratechnologies' investing sentiment overview a quick insight into current market opportunities from investing in Theratechnologies. Many technical investors use Theratechnologies stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Theratechnologies |
Neurocrine gives up on Parkinsons drug Ongentys FiercePharma
Read at news.google.com
 |
Theratechnologies Fundamental Analysis
We analyze Theratechnologies' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Theratechnologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Theratechnologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Operating Margin
Operating Margin Comparative Analysis
Theratechnologies is currently under evaluation in operating margin category among its peers. Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Theratechnologies Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Theratechnologies stock to make a market-neutral strategy. Peer analysis of Theratechnologies could also be used in its relative valuation, which is a method of valuing Theratechnologies by comparing valuation metrics with similar companies.
Peers
Theratechnologies Related Equities
| PRN | Profound Medical | 3.59 | ||||
| ABR | Arbor Metals | 3.03 | ||||
| RCI-A | Rogers Communications | 1.04 | ||||
| VZ | Verizon Communications | 0.15 | ||||
| AWI | Advent Wireless | 0.00 | ||||
| DCM | Data Communications | 0.51 | ||||
| QIPT | Quipt Home | 1.15 | ||||
| SDI | Stampede Drilling | 5.00 |
Check out Theratechnologies Hype Analysis, Theratechnologies Correlation and Theratechnologies Performance. To learn how to invest in Theratechnologies Stock, please use our How to Invest in Theratechnologies guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.